First Horizon Advisors’s Cano Health, Inc. CANO Stock Holding History

First Horizon Advisors’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1	Closed	–	–	2606
2022 Q1	$0	Buy	+1	New	+$630	﹤0.01%	2395
2021 Q4	–	Sell	-20	Closed	-$25K	–	2480
2021 Q3	$25K	Hold	20	–	–	﹤0.01%	1202
2021 Q2	$24K	Hold	20	–	–	﹤0.01%	1057
2021 Q1	$26K	Buy	+20	New	+$28.3K	﹤0.01%	988

Other funds holding CANO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

First Horizon Advisors's CANO Position: Q2 2022 in Review

First Horizon Advisors sold out of Cano Health, Inc. (CANO) in Q2 2022, closing a stake of 1 share.

First Horizon Advisors first reported a position in CANO in Q1 2021 and held it in 4 quarters. The position peaked at $26K in Q1 2021. 144 funds tracked by Wall St. Rank hold CANO as of Q2 2022.

First Horizon Advisors reported no remaining Cano Health, Inc. position as of Q2 2022 after selling out during the quarter.
First Horizon Advisors sold 1 Cano Health, Inc. share in Q2 2022.
First Horizon Advisors first reported a position in Cano Health, Inc. in Q1 2021 and held it in 4 quarters.
First Horizon Advisors's Cano Health, Inc. position peaked at $26K in Q1 2021.
144 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q2 2022.

Based on First Horizon Advisors's 13F filing for Q2 2022, filed 2 Aug 2022.